Cargando…
Performance of second-trimester maternal biochemistry screening (quadruple test vs. triple test) for trisomy 21: An Indian experience
BACKGROUND & OBJECTIVES: Down syndrome (DS) is one of the most common causes of developmental delay. In India, there is no protocol for prenatal screening of DS. Second-trimester biochemical screening is still being done by triple test. Quadruple test is with better sensitivity and specificity b...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210531/ https://www.ncbi.nlm.nih.gov/pubmed/35417990 http://dx.doi.org/10.4103/ijmr.IJMR_1034_19 |
_version_ | 1784730176635011072 |
---|---|
author | Sablok, Aanchal Sharma, Akshatha Ahmed, Chanchal Singh Kaul, Anita |
author_facet | Sablok, Aanchal Sharma, Akshatha Ahmed, Chanchal Singh Kaul, Anita |
author_sort | Sablok, Aanchal |
collection | PubMed |
description | BACKGROUND & OBJECTIVES: Down syndrome (DS) is one of the most common causes of developmental delay. In India, there is no protocol for prenatal screening of DS. Second-trimester biochemical screening is still being done by triple test. Quadruple test is with better sensitivity and specificity but is not advised routinely. So, the objective of this study was to evaluate the sensitivity and accuracy of the second-trimester screening (quadruple test with genetic sonogram) for trisomy 21 as compared to biochemical testing. METHODS: This retrospective observational study was carried out in a Fetal Medicine Centre to analyze the odds of being affected with DS, given a positive risk (OAPR) upon screening in the quadruple test; triple test and quadruple test plus a genetic sonogram for high-risk singleton pregnancies (in view of advanced maternal age; an anomaly scan showing some abnormality, etc). RESULTS: 3175 high-risk singleton pregnancies were screened for trisomy 21. 394 women underwent amniocentesis on the basis of triple test, quadruple test or quadruple plus genetic sonogram positive. 17 foetuses were diagnosed to have DS. The quadruple test was found to have a higher OAPR as compared to the triple test (1:30.1 as compared to 1: 40.2). Quadruple test plus the genetic sonogram was found to have the highest OAPR of 1:6. INTERPRETATION & CONCLUSIONS: Best screening for trisomy 21 is provided with quadruple test with genetic sonogram which can lower the rates of unnecessary amniocentesis in high-risk population. |
format | Online Article Text |
id | pubmed-9210531 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-92105312022-06-22 Performance of second-trimester maternal biochemistry screening (quadruple test vs. triple test) for trisomy 21: An Indian experience Sablok, Aanchal Sharma, Akshatha Ahmed, Chanchal Singh Kaul, Anita Indian J Med Res Original Article BACKGROUND & OBJECTIVES: Down syndrome (DS) is one of the most common causes of developmental delay. In India, there is no protocol for prenatal screening of DS. Second-trimester biochemical screening is still being done by triple test. Quadruple test is with better sensitivity and specificity but is not advised routinely. So, the objective of this study was to evaluate the sensitivity and accuracy of the second-trimester screening (quadruple test with genetic sonogram) for trisomy 21 as compared to biochemical testing. METHODS: This retrospective observational study was carried out in a Fetal Medicine Centre to analyze the odds of being affected with DS, given a positive risk (OAPR) upon screening in the quadruple test; triple test and quadruple test plus a genetic sonogram for high-risk singleton pregnancies (in view of advanced maternal age; an anomaly scan showing some abnormality, etc). RESULTS: 3175 high-risk singleton pregnancies were screened for trisomy 21. 394 women underwent amniocentesis on the basis of triple test, quadruple test or quadruple plus genetic sonogram positive. 17 foetuses were diagnosed to have DS. The quadruple test was found to have a higher OAPR as compared to the triple test (1:30.1 as compared to 1: 40.2). Quadruple test plus the genetic sonogram was found to have the highest OAPR of 1:6. INTERPRETATION & CONCLUSIONS: Best screening for trisomy 21 is provided with quadruple test with genetic sonogram which can lower the rates of unnecessary amniocentesis in high-risk population. Wolters Kluwer - Medknow 2021-11 /pmc/articles/PMC9210531/ /pubmed/35417990 http://dx.doi.org/10.4103/ijmr.IJMR_1034_19 Text en Copyright: © 2022 Indian Journal of Medical Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Sablok, Aanchal Sharma, Akshatha Ahmed, Chanchal Singh Kaul, Anita Performance of second-trimester maternal biochemistry screening (quadruple test vs. triple test) for trisomy 21: An Indian experience |
title | Performance of second-trimester maternal biochemistry screening (quadruple test vs. triple test) for trisomy 21: An Indian experience |
title_full | Performance of second-trimester maternal biochemistry screening (quadruple test vs. triple test) for trisomy 21: An Indian experience |
title_fullStr | Performance of second-trimester maternal biochemistry screening (quadruple test vs. triple test) for trisomy 21: An Indian experience |
title_full_unstemmed | Performance of second-trimester maternal biochemistry screening (quadruple test vs. triple test) for trisomy 21: An Indian experience |
title_short | Performance of second-trimester maternal biochemistry screening (quadruple test vs. triple test) for trisomy 21: An Indian experience |
title_sort | performance of second-trimester maternal biochemistry screening (quadruple test vs. triple test) for trisomy 21: an indian experience |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210531/ https://www.ncbi.nlm.nih.gov/pubmed/35417990 http://dx.doi.org/10.4103/ijmr.IJMR_1034_19 |
work_keys_str_mv | AT sablokaanchal performanceofsecondtrimestermaternalbiochemistryscreeningquadrupletestvstripletestfortrisomy21anindianexperience AT sharmaakshatha performanceofsecondtrimestermaternalbiochemistryscreeningquadrupletestvstripletestfortrisomy21anindianexperience AT ahmedchanchalsingh performanceofsecondtrimestermaternalbiochemistryscreeningquadrupletestvstripletestfortrisomy21anindianexperience AT kaulanita performanceofsecondtrimestermaternalbiochemistryscreeningquadrupletestvstripletestfortrisomy21anindianexperience |